AAAAAA
Results: 1-25/32
Authors:
Quittan, M
Wiesinger, GF
Crevenna, R
Nuhr, MJ
Posch, M
Hulsmann, M
Muller, D
Pacher, R
Fialka-Moser, V
Citation: M. Quittan et al., Cross-cultural adaptation of the Minnesota living with heart failure questionnaire for German-speaking patients, J REHAB MED, 33(4), 2001, pp. 182-186
Authors:
Mehrabi, MR
Ekmekcioglu, C
Stanek, B
Thalhammer, T
Tamaddon, F
Pacher, R
Steiner, GE
Wild, T
Grimm, M
Spieckermann, PG
Mall, G
Glogar, HD
Citation: Mr. Mehrabi et al., Angiogenesis stimulation in explanted hearts from patients pre-treated with intravenous prostaglandin E-1, J HEART LUN, 20(4), 2001, pp. 465-473
Authors:
Hulsmann, M
Sturm, B
Pacher, R
Berger, R
Bojic, A
Frey, B
Stanek, B
Citation: M. Hulsmann et al., Long-term effect of atenolol on ejection fraction, symptoms, and exercise variables in patients with advanced left ventricular dysfunction, J HEART LUN, 20(11), 2001, pp. 1174-1180
Authors:
Quittan, M
Wiesinger, GF
Sturm, B
Puig, S
Mayr, W
Sochor, A
Paternostro, T
Resch, KL
Pacher, R
Fialka-Moser, V
Citation: M. Quittan et al., Improvement of thigh muscles by neuromuscular electrical stimulation in patients with refractory heart failure - A single-blind, randomized, controlled trial, AM J PHYS M, 80(3), 2001, pp. 206-214
Authors:
Stanek, B
Frey, B
Hulsmann, M
Berger, R
Sturm, B
Strametz-Juranek, J
Bergler-Klein, J
Moser, P
Bojic, A
Hartter, E
Pacher, R
Citation: B. Stanek et al., Prognostic evaluation of neurohumoral plasma levels before and during beta-blocker therapy in advanced left ventricular dysfunction, J AM COL C, 38(2), 2001, pp. 436-442
Authors:
Pacher, R
Citation: R. Pacher, Pathogenesis of heart failure, SEM NEPHROL, 21(3), 2001, pp. 273-277
Authors:
Quittan, M
Wiesinger, GF
Crevenna, R
Nuhr, MJ
Sochor, A
Pacher, R
Fialka-Moser, V
Citation: M. Quittan et al., Isokinetic strength testing in patients with chronic heart failure - A reliability study, INT J SP M, 22(1), 2001, pp. 40-44
Authors:
Sandner, SE
Wieselthaler, G
Zuckermann, A
Taghavi, S
Schmidinger, H
Pacher, R
Ploner, M
Laufer, G
Wolner, E
Grimm, M
Citation: Se. Sandner et al., Survival benefit of the implantable cardioverter-defibrillator in patientson the waiting list for cardiac transplantation, CIRCULATION, 104(12), 2001, pp. I171-I176
Authors:
Berger, R
Stanek, B
Hulsmann, M
Frey, B
Heher, S
Pacher, R
Neunteufl, T
Citation: R. Berger et al., Effects of endothelin A receptor blockade on endothelial function in patients with chronic heart failure, CIRCULATION, 103(7), 2001, pp. 981-986
Authors:
Wieselthaler, GM
Schima, H
Lassnigg, AM
Dworschak, M
Pacher, R
Grimm, M
Wolner, E
Citation: Gm. Wieselthaler et al., Lessons learned from the first clinical implants of the DeBakey ventricular assist device axial pump: A single center report, ANN THORAC, 71(3), 2001, pp. S139-S143
Authors:
Sturm, B
Pacher, R
Strametz-Juranek, J
Berger, R
Frey, B
Stanek, B
Citation: B. Sturm et al., Effect of beta 1 blockade with atenolol on progression of heart failure inpatients pretreated with high-dose enalapril, EUR J HE FA, 2(4), 2000, pp. 407-412
Authors:
Mohacsi, P
Deng, MC
Murphy, R
Bergh, CH
Gronda, E
Komajda, M
Pacher, R
Spinar, J
Swedberg, K
Cleland, JF
Citation: P. Mohacsi et al., Implantable left ventricular assist systems (LVAS): Recent results. A report from a series of meetings sponsored by the Study Group on Advanced HeartFailure of the Working Group on Heart Failure, EUR J HE FA, 2(1), 2000, pp. 13-18
Authors:
Kos, T
Moser, P
Yilmatz, N
Mayer, G
Pacher, R
Hallstrom, S
Citation: T. Kos et al., High-performance liquid chromatographic determination of p-aminohippuric acid and iothalamate in human serum and urine: comparison of two sample preparation methods, J CHROMAT B, 740(1), 2000, pp. 81-85
Authors:
Berger, R
Kuchling, G
Frey, B
Kozanly, I
Pacher, R
Stanek, B
Citation: R. Berger et al., ACE inhibitor dosage at the time of listing predicts survival, J HEART LUN, 19(2), 2000, pp. 127-133
Authors:
Berger, R
Strecker, K
Hulsmann, M
Frey, B
Pacher, R
Stanek, B
Citation: R. Berger et al., Experience with beta-blocker therapy in patients with advanced heart failure evaluated for HTx, J HEART LUN, 19(11), 2000, pp. 1081-1088
Authors:
Hulsmann, M
Stefenelli, T
Berger, R
Sturm, B
Parkner, A
Zuckermann, A
Woloszczuk, W
Pacher, R
Citation: M. Hulsmann et al., Response of right ventricular function to prostaglandin E1 infusion predicts outcome for severe chronic heart failure patients awaiting urgent transplantation, J HEART LUN, 19(10), 2000, pp. 939-945
Authors:
Spieker, LE
Mitrovic, V
Noll, G
Pacher, R
Schulze, MR
Muntwyler, J
Schalcher, C
Kiowski, W
Luscher, TF
Citation: Le. Spieker et al., Acute hemodynamic and neurohumoral effects of selective ETA receptor blockade in patients with congestive heart failure, J AM COL C, 35(7), 2000, pp. 1745-1752
Authors:
Stanek, B
Pacher, R
Citation: B. Stanek et R. Pacher, Intravenous therapy far advanced heart failure, CURR OPIN C, 15(3), 2000, pp. 156-160
Authors:
Kostner, K
Clodi, M
Bodlaj, G
Hoffmann, U
Hermann, K
Maurer, G
Pacher, R
Horl, WH
Citation: K. Kostner et al., Urinary apo(a) excretion is not altered by changes in glomerular filtration rate and renal plasma flow in healthy males, WIEN KLIN W, 112(3), 2000, pp. 121-125
Authors:
Frey, B
Pacher, R
Locker, G
Bojic, A
Hartter, E
Woloszczuk, W
Stanek, B
Citation: B. Frey et al., Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients, CHEST, 117(6), 2000, pp. 1713-1719
Authors:
Wieselthaler, GM
Schima, H
Hiesmayr, M
Pacher, R
Laufer, G
Noon, GP
DeBakey, M
Wolner, E
Citation: Gm. Wieselthaler et al., First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation, CIRCULATION, 101(4), 2000, pp. 356-359
Authors:
Pacher, R
Stanek, B
Citation: R. Pacher et B. Stanek, Ambulatory vasodilator therapy in heart failure: systematic review of the literature and personal observational experience, EUR J HE FA, 1(3), 1999, pp. 263-268
Authors:
Stanek, B
Sturm, B
Frey, B
Hulsmann, M
Bojic, A
Berger, R
Rodler, S
Locker, G
Grimm, M
Laufer, G
Pacher, R
Citation: B. Stanek et al., Bridging to heart transplantation: Prostaglandin E-1 versus prostacyclin versus dobutamine, J HEART LUN, 18(4), 1999, pp. 358-366
Authors:
Pacher, R
Stanek, B
Citation: R. Pacher et B. Stanek, Prostaglandin E-1 bridge to heart transplantation - methods, technique, results, Z KARDIOL, 88, 1999, pp. 33-35
Authors:
Quittan, M
Sochor, A
Wiesinger, GF
Kollmitzer, J
Sturm, B
Pacher, R
Mayr, W
Citation: M. Quittan et al., Strength improvement of knee extensor muscles in patients with chronic heart failure by neuromuscular electrical stimulation, ARTIF ORGAN, 23(5), 1999, pp. 432-435